• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience.同种异体脱细胞基质疗法治疗糖尿病足伤口的疗效:初步经验。
Int Wound J. 2005 Jun;2(2):161-5. doi: 10.1111/j.1742-4801.2005.00099.x.
2
Outcomes of hyaluronan therapy in diabetic foot wounds.透明质酸治疗糖尿病足伤口的效果
Diabetes Res Clin Pract. 2003 Feb;59(2):123-7. doi: 10.1016/s0168-8227(02)00197-3.
3
Outcomes of subatmospheric pressure dressing therapy on wounds of the diabetic foot.负压敷料治疗糖尿病足伤口的疗效
Ostomy Wound Manage. 2002 Apr;48(4):64-8.
4
The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study.脱细胞真皮再生组织基质在下肢伤口治疗中的应用:一项为期16周的前瞻性初步研究。
Int Wound J. 2006 Sep;3(3):181-7. doi: 10.1111/j.1742-481X.2006.00209.x.
5
A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.一项前瞻性、随机、对照、多中心临床试验,旨在研究脱细胞异体人真皮网状层与标准治疗方法相比,在治疗慢性糖尿病足溃疡时的愈合率、安全性及愈合成本。
Int Wound J. 2017 Apr;14(2):307-315. doi: 10.1111/iwj.12600. Epub 2016 Apr 12.
6
Outcomes of an Esterified Hyaluronic Acid Matrix in the Treatment of Chronic Lower Extremity Wounds: A Case Series.酯化透明质酸基质治疗慢性下肢伤口的疗效:病例系列
Wounds. 2018 Dec;30(12):367-371.
7
Primary wound closure of diabetic foot ulcers by debridement and stitching.通过清创和缝合对糖尿病足溃疡进行一期伤口闭合。
J Wound Care. 2016 Nov 2;25(11):650-654. doi: 10.12968/jowc.2016.25.11.650.
8
Use of three-dimensional acellular collagen matrix in deep or tunnelling diabetic foot ulcers: a retrospective case series.三维去细胞胶原基质在深部或隧道性糖尿病足溃疡中的应用:回顾性病例系列。
J Wound Care. 2024 Sep 1;33(Sup9):S5-S16. doi: 10.12968/jowc.2024.0176.
9
Use of Ovine-based Collagen Extracellular Matrix and Gentian Violet/Methylene Blue Antibacterial Foam Dressings to Help Improve Clinical Outcomes in Lower Extremity Wounds: A Retrospective Cohort Study.使用基于绵羊的胶原蛋白细胞外基质和龙胆紫/亚甲蓝抗菌泡沫敷料以帮助改善下肢伤口的临床结局:一项回顾性队列研究。
Wounds. 2017 Apr;29(4):107-114.
10
Acellular Fish Skin Graft Use for Diabetic Lower Extremity Wound Healing: A Retrospective Study of 58 Ulcerations and a Literature Review.脱细胞鱼皮移植用于糖尿病下肢伤口愈合:58例溃疡的回顾性研究及文献综述
Wounds. 2019 Oct;31(10):262-268. Epub 2019 Aug 21.

引用本文的文献

1
Granular Porous Nanofibrous Microspheres Enhance Cellular Infiltration for Diabetic Wound Healing.多孔纳米纤维微球增强细胞浸润促进糖尿病创面愈合。
ACS Nano. 2024 Oct 15;18(41):28335-28348. doi: 10.1021/acsnano.4c10044. Epub 2024 Oct 2.
2
Effectiveness and safety of dermal matrix used for diabetic foot ulcer: a systematic review and meta-analysis of randomized controlled trials.用于糖尿病足溃疡的真皮基质的有效性和安全性:随机对照试验的系统评价和荟萃分析。
BMC Endocr Disord. 2024 Feb 20;24(1):23. doi: 10.1186/s12902-024-01550-3.
3
Exploring the Place of Fish Skin Grafts with Omega-3 in Pediatric Wound Management.探索含欧米伽-3的鱼皮移植在儿童伤口处理中的应用
J Clin Med. 2023 Dec 25;13(1):112. doi: 10.3390/jcm13010112.
4
A Prospective Randomized Controlled Multicenter Clinical Trial Comparing Paste-Type Acellular Dermal Matrix to Standard Care for the Treatment of Chronic Wounds.一项比较糊状脱细胞真皮基质与标准护理治疗慢性伤口的前瞻性随机对照多中心临床试验。
J Clin Med. 2022 Apr 14;11(8):2203. doi: 10.3390/jcm11082203.
5
Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing.管理糖尿病足溃疡:伤口愈合的药物治疗。
Drugs. 2021 Jan;81(1):29-56. doi: 10.1007/s40265-020-01415-8.
6
Application of a paste-type acellular dermal matrix for coverage of chronic ulcerative wounds.糊剂型脱细胞真皮基质在慢性溃疡性伤口覆盖中的应用。
Arch Plast Surg. 2018 Nov;45(6):564-571. doi: 10.5999/aps.2018.00605. Epub 2018 Nov 15.
7
The marine Omega3 wound matrix for treatment of complicated wounds: A multicenter experience report.用于治疗复杂伤口的海洋欧米伽3伤口基质:多中心经验报告。
Gefasschirurgie. 2018;23(Suppl 2):46-55. doi: 10.1007/s00772-018-0428-2. Epub 2018 Aug 1.
8
Slow to heel: a literature review on the management of diabetic calcaneal ulceration.愈合缓慢:糖尿病性跟骨溃疡管理的文献回顾。
Int Wound J. 2018 Apr;15(2):205-211. doi: 10.1111/iwj.12839. Epub 2018 Feb 12.
9
Retrospective observational analysis of the use of an architecturally unique dermal regeneration template (Derma Pure®) for the treatment of hard-to-heal wounds.对一种具有独特结构的皮肤再生模板(Derma Pure®)用于治疗难愈合伤口的回顾性观察分析。
Int Wound J. 2017 Aug;14(4):666-672. doi: 10.1111/iwj.12667. Epub 2016 Sep 13.
10
Wound Healing: Biologics, Skin Substitutes, Biomembranes and Scaffolds.创伤愈合:生物制剂、皮肤替代物、生物膜和支架。
Healthcare (Basel). 2014 Sep 10;2(3):356-400. doi: 10.3390/healthcare2030356.

本文引用的文献

1
Preventing foot ulcers in patients with diabetes.预防糖尿病患者足部溃疡
JAMA. 2005 Jan 12;293(2):217-28. doi: 10.1001/jama.293.2.217.
2
Stimulation of skin repair is dependent on fibroblast source and presence of extracellular matrix.皮肤修复的刺激取决于成纤维细胞来源和细胞外基质的存在。
Tissue Eng. 2004 Jul-Aug;10(7-8):1054-64. doi: 10.1089/ten.2004.10.1054.
3
Closure of abdominal wall defects using acellular dermal matrix.使用脱细胞真皮基质闭合腹壁缺损。
J Trauma. 2004 Jun;56(6):1266-75. doi: 10.1097/01.ta.0000068241.66186.00.
4
Neurosurgical reconstruction with acellular cadaveric dermal matrix.使用脱细胞尸体真皮基质进行神经外科重建。
Ann Plast Surg. 2004 Jun;52(6):571-7. doi: 10.1097/01.sap.0000122651.12811.3d.
5
[Collagen changes of allografting an acellular dermal matrix].[同种异体脱细胞真皮基质移植的胶原变化]
Zhonghua Zheng Xing Wai Ke Za Zhi. 2004 Jan;20(1):51-2.
6
Reduction in diabetes-related lower-extremity amputations in The Netherlands: 1991-2000.荷兰糖尿病相关下肢截肢率的下降:1991 - 2000年
Diabetes Care. 2004 May;27(5):1042-6. doi: 10.2337/diacare.27.5.1042.
7
Effective management of major lower extremity wounds using an acellular regenerative tissue matrix: a pilot study.使用脱细胞再生组织基质对下肢主要伤口进行有效管理:一项试点研究。
Orthopedics. 2004 Jan;27(1 Suppl):s145-9. doi: 10.3928/0147-7447-20040102-14.
8
Effect of collagen matrices on dermal wound healing.胶原蛋白基质对皮肤伤口愈合的影响。
Adv Drug Deliv Rev. 2003 Nov 28;55(12):1595-611. doi: 10.1016/j.addr.2003.08.003.
9
Plantar pressures in fiberglass total contact casts vs. a new diabetic walking boot.玻璃纤维全接触石膏与新型糖尿病步行靴的足底压力比较
Foot Ankle Int. 2003 Jan;24(1):45-9. doi: 10.1177/107110070302400107.
10
Blood flow changes in diabetic foot ulcers treated with dermal replacement therapy.采用真皮替代疗法治疗糖尿病足溃疡时的血流变化。
J Foot Ankle Surg. 2002 Jul-Aug;41(4):233-7. doi: 10.1016/s1067-2516(02)80020-5.

同种异体脱细胞基质疗法治疗糖尿病足伤口的疗效:初步经验。

Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience.

作者信息

Martin Billy R, Sangalang Melinda, Wu Stephanie, Armstrong David G

机构信息

Department of Surgery, Southern Arizona Veterans Affairs Medical Center, Tucson, AZ, USA.

出版信息

Int Wound J. 2005 Jun;2(2):161-5. doi: 10.1111/j.1742-4801.2005.00099.x.

DOI:10.1111/j.1742-4801.2005.00099.x
PMID:16722865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7951241/
Abstract

The purpose of this study was to evaluate outcomes of persons with UT grade 2A neuropathic diabetic foot wounds treated with an acellular matrix. Data were abstracted for 17 consecutive patients with diabetes--76.5% males, aged 61.5 +/- 8.5 years with a mean glycated haemoglobin of 9.2 +/- 2.2% presenting for care at a large, multidisciplinary wound care centre. All patients received surgical debridement for their diabetic foot wounds and were placed on therapy consisting of a single application of an acellular matrix graft (GraftJacket; Wright Medical Technologies, Arlington, TN, USA) with dressing changes taking place weekly. Outcomes evaluated included time to complete wound closure and proportion of patients achieving wound closure in 20 weeks. Acellular matrix therapy was used as initial therapy and was sutured or stapled in place under a silicone-based non adherent dressing. Therapy was then followed by a moisture-retentive dressing until complete epithelialisation. In total, 82.4% of wounds measuring a mean 4.6 +/- 3.2 cm(2) healed in the 20-week evaluation period. For those that healed in this period, healing took place in a mean 8.9 +/- 2.7 weeks. We conclude that a regimen consisting of moist wound healing using an acellular matrix dressing may be a useful adjunct to appropriate diabetic foot ulcer care for deep, non-infected, non-ischaemic wounds. We await the completion of further trials in this area to confirm or refute this initial assessment.

摘要

本研究的目的是评估采用脱细胞基质治疗2A级糖尿病神经病变足溃疡患者的疗效。我们提取了一家大型多学科伤口护理中心连续17例糖尿病患者的数据,这些患者中男性占76.5%,年龄为61.5±8.5岁,平均糖化血红蛋白为9.2±2.2%。所有患者均接受了糖尿病足溃疡的手术清创,并接受了单一应用脱细胞基质移植物(GraftJacket;美国田纳西州阿灵顿市Wright Medical Technologies公司)的治疗,每周更换敷料。评估的结果包括伤口完全闭合的时间以及20周内实现伤口闭合的患者比例。脱细胞基质疗法作为初始疗法,在硅基非粘性敷料下缝合或钉合到位。然后采用保湿敷料直至完全上皮化。在20周的评估期内,平均面积为4.6±3.2 cm²的伤口中,82.4%愈合。对于在此期间愈合的伤口,平均愈合时间为8.9±2.7周。我们得出结论,对于深度、非感染、非缺血性伤口,采用脱细胞基质敷料进行湿性伤口愈合的方案可能是适当糖尿病足溃疡护理的有用辅助手段。我们等待该领域进一步试验的完成,以证实或反驳这一初步评估。